What are you looking for? Search Common searches: Intranet, Contact, Map, Professionals, Teaching units, Research groups, Fulltext search Tipus de contingut Professionals Projects Teaching Units Collaborating entities News Activities - Any - Search Activities Exposició L'altra mirada de la recerca- Què hi ha al darrere de les imatges científiques? Exposició L’altra mirada de la recerca – cicle de xerrades Lloc: Sala cotxeres del Palau Robert (Passeig de Gràcia, 107, 08008 Barcelona) Dies: 2, 9, 16 i 23 de febrer Horari: de 18h a 19h Activities Webinar IRISCAT- Dra. Clara Montagut "Utilitat clínica de la biòpsia líquida en càncer colorectal" Vogelstein y colegas describieron hace más de 20 años un modelo de carcinogénesis colorrectal basado en un acúmulo de mutaciones somáticas de forma secuencial. Así pues, la presencia de mutaciones somáticas define la presencia de cáncer. Tradicionalmente, las mutaciones somáticas se determinan en Activities Webinar IRISCAT- Dra. Laura Furlong "Coping with the gene-disease big data: The DisGeNET platform" One of the most pressing challenges in genomic medicine is to understand the impact of genomic variation in disease and drug response. The large-scale interrogation of the human genome has uncovered hundreds of thousands of disease-associated loci. However, the identification of variants of clini Activities Webinar VHIR- Dr. Joan Seoane "LIF as a regulator of the innate immune response to antigens" I will discuss about the parallelisms of viral infection and cancer and how virus and tumors can use similar molecular mechanisms to evade the immune system of the host. I will talk about our research in the field of cancer and how we identified LIF as a potent immunosuppressor in the context of Activities Webinar VHIR -Dr. Ricardo Pujol "Autoinmunidad órgano-específica 2021: Re-interpretación de la hipótesis de 1983 sobre el papel la expresión aberrante de HLA por las células endocrinas en la patogénesis de la respuesta autoinmune" En su inicio la investigación en las enfermedades autoinmunes se centró en la detección de auto-anticuerpos y sus correspondientes auto-antígenos, pero la existencia de una respuesta celular concomitante, aunque sospechada, no se podía estudiar. Sin embargo a partir del descubrimiento de la Activities Webinar IRISCAT- Dr. Rafael de Cid "GCAT cohort. Anatomia genòmica de la COVID19. Com les dades genòmiques ens ajuden a entendre la COVID19" El brot epidèmic del SARS-CoV-2 ha posat a prova la societat i, en especial, la comunitat científica, en la que s'han dipositat totes les esperances de trobar una solució ràpida al problema. En poc temps hem hagut de mostrar una gran creativitat i capacitat de treball global, i s’ha arribat a gra Activities Webinar IRISCAT- Dra. Ximena Goldberg "Risk factors for depression and anxiety during the pandemic" Depression was already the second leading cause of global burden of disease before the beginning of the COVID-19 pandemic almost one year ago. Mental health conditions were associated with global economic costs rising to U$S 1 trillion per year. These estimates are expected to further increase in Activities Dia Mundial del Riñón. Semipresencial y Online 10:00 h Benvinguda per part del Dr. Roman, director Assistencial de l’Hospital Activities Webinar VHIR- Dra. Pilar Sánchez "The brain microenvironment defines the aggressiveness of gliomas" Cancer growth is driven by the complex interplay between tumor cells and their supportive microenvironment. However, this interaction is still not fully understood, especially for gliomas, which are very aggressive tumors growing in the complex brain milieu. Here, I will present some recent Activities Webinar IRISCAT- Dra. Gemma Moncunill "Seven-month kinetics of SARS-CoV-2 antibodies and protective role of pre-existing antibodies to seasonal human coronaviruses on COVID-19" Unraveling the long-term kinetics of antibodies to SARS-CoV-2 and its determinants is essential to understand protective immunity to COVID-19 and devise effective surveillance strategies. In addition, understanding the extent of antibody cross-reactivity with other human coronaviruses (HCoV Pagination Previous page ‹‹ Page 14 Next page ››